Catalent and Novo Holdings fulfill all regulatory closing conditions for pending transaction
Transaction expected to close in the coming days SOMERSET, N.J. & COPENHAGEN, Denmark — (BUSINESS WIRE) — Catalent, Inc. (“Catalent,” NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings A/S (“Novo